Agent-Assisted Evidence Synthesis: A Survey
Summary
An exploratory systematic map of how AI and LLM agents are being used across the evidence-synthesis pipeline. It reconciles competing stage vocabularies, organizes the retained literature by workflow stage, contribution, evidence type, and setting, and synthesizes what selected studies show about performance measurement, human baselines, disclosure norms, and multi-model design. The retained map is screening- and medicine-heavy, while the reported results are heterogeneous and difficult to compare: metrics, aggregation, reference labels, and deferral can all change the apparent verdict. Guidance repeatedly calls for disclosure of the tool, task, human role, configuration, and verification, but the selected proposals cover different subsets and their evidence notes report no validation or adoption evidence. Ensemble and human–AI deferral designs report conditional gains, while agent reviewer independence remains an open measurement problem rather than an established construct.
Links
Reading list
The works that anchor the map, curated from the selected evidence notes and organized by the survey’s taxonomy, with the method foundations and comparison points that bound its synthesis. Entries link the original paper (DOI where one exists) and our notes on it (library pages where ingested, our evidence notes in the record otherwise).
Method foundations
| Paper | What | Venue · Year | Notes |
|---|---|---|---|
| Guidelines for Performing Systematic Literature Reviews in Software Engineering | The SLR method canon for SE | EBSE Report · 2007 | kitchenham2007 |
| Systematic Mapping Studies in Software Engineering | Defines the systematic-map genre | EASE · 2008 | petersen2008 |
| Guidelines for Snowballing in Systematic Literature Studies | Snowballing search guidelines | EASE · 2014 | wohlin2014 |
| The PRISMA 2020 Statement | The reporting standard for systematic reviews | BMJ · 2021 | page2021 |
Landscape and lineage
| Paper | What | Venue · Year | Notes |
|---|---|---|---|
| Automation of Systematic Literature Reviews | Pre-LLM landscape of SLR automation (41 studies, 2006–2020) | IST · 2021 | notes |
| Automated Support for Searching and Selecting Evidence in Software Engineering | The medicine-vs-SE adoption gap, measured pre-LLM | SEAA · 2021 | notes |
| Potential Roles of Large Language Models in the Production of Systematic Reviews and Meta-Analyses | Stage-by-stage map of where LLMs can assist | JMIR · 2024 | notes |
| Large Language Models, Updates, and Evaluation of Automation Tools for Systematic Reviews | ICASR community report on tools and evaluation | Syst Rev · 2024 | notes |
| The Phases of Living Evidence Synthesis Using AI | Phase model and tool inventory for living evidence | JMIR · 2026 | notes |
Screening
| Paper | What | Venue · Year | Notes |
|---|---|---|---|
| Enhancing Title and Abstract Screening with GPT-3.5 Turbo | In one review case, eight sequential prompt variants produced materially different reported sensitivities | BMJ EBM · 2023 | notes |
| Screening Articles for Systematic Reviews With ChatGPT | Early cross-corpus screening evaluation; stability is not validity | J Comput Lang · 2024 | notes |
| GPT-3.5 Turbo and GPT-4 Turbo in Title and Abstract Screening | Same-prompt comparison: GPT-4 Turbo had higher specificity and similar sensitivity | JMIR Med Inform · 2025 | notes |
| SESR-Eval: Dataset for Evaluating LLMs in Title-Abstract Screening | 9-LLM × 24-review benchmark; none of the tested models met the study’s proposed deployment bar | ESEM · 2025 | notes |
| Empirical Evaluation of Open-Source LLMs for Paper Selection | Abstract-only evidence: open-weight models screened more conservatively than GPT-4.1 | SANER-C · 2026 | notes |
| LLM-Based Test Oracles: Source-of-Authority Taxonomy | A disclosed-adoption exemplar: LLM pre-filter with audits, reported under PRISMA | arXiv · 2026 | notes |
Extraction and appraisal
| Paper | What | Venue · Year | Notes |
|---|---|---|---|
| Agreement in Risk-of-Bias Assessment Between RobotReviewer and Human Reviewers | Abstract-only evidence: agreement with the source Cochrane reviews’ own human risk-of-bias judgments ranged from kappa 0.60 (allocation concealment) to 0.04 (blinding of outcome assessors) across domains — a per-domain spread an aggregate accuracy figure would hide; pre-LLM tool, 190 nursing trials | J Nurs Scholarsh · 2021 | notes |
| Accuracy and Efficiency of Machine Learning–Assisted Risk-of-Bias Assessments | Abstract-only evidence: a rare RCT-grade automation study found noninferiority, not superiority | Ann Intern Med · 2022 | notes |
| (Semi)automated Approaches to Data Extraction for Systematic Reviews | Living review of extraction approaches in social science (23 studies) | F1000Research · 2024 | notes |
| Data Extraction for Systematic Mapping Study Using a Large Language Model | Abstract-only evidence: an LLM extraction proof-of-concept in SE | ESEM · 2024 | notes |
| Benchmarking Human–AI Collaboration for Common Evidence Appraisal Tools | Retrospective benchmark: agreement-gated deferral outperformed humans alone and LLM ensembles on two easier instruments | J Clin Epi · 2024 | woelfle2024 |
Ensembles and end-to-end systems
| Paper | What | Venue · Year | Notes |
|---|---|---|---|
| Ensemble of Deep Learning Language Models for Living Systematic Reviews | Five same-family BERT classifiers: configuration reported, no diversity or correlation statistic measured anywhere; unanimity plus a confidence threshold trades coverage for accuracy — ~98.5% F1 on ~50% of records, against one crowdsourced annotation team’s labels | Syst Rev · 2023 | notes |
| Dual-Model LLM Ensemble Reaches Near-Perfect Sensitivity for Screening | Preprint: cross-vendor OR ensemble reached 99.7% sensitivity on author-adjudicated labels (94.0–94.5% on original labels); no family-diversity ablation | medRxiv · 2025 | fagerberg2025 |
| LLM-Based Multiagent Collaboration for Abstract Screening | The only selected evidence record measuring inter-agent diversity — Spearman 0.48–0.56 among three cross-vendor agents, which a debate round raised while losing the ensemble’s edge; gains are over the best single agent on a benchmark’s original Cochrane inclusion labels, and vendor, scale, and training data vary together, so no factor is isolated | Biol Methods Protoc · 2026 | notes |
| A PRISMA-Aligned Agentic Framework for Medical Systematic Reviews | Preprint evaluated on an author-built benchmark: decomposition, structured artifacts, human review, and no redundancy | medRxiv · 2026 | notes |
Norms, reporting, and evaluation methodology
| Paper | What | Venue · Year | Notes |
|---|---|---|---|
| Guidance for Using AI for Title and Abstract Screening | Pre-LLM guidance that rejects fully autonomous thresholding and separately risk-ranks post-truncation options | BMC Med Res Methodol · 2021 | notes |
| Responsible Integration of AI in Rapid Reviews | Cochrane Rapid Reviews position statement, endorsing RAISE | Cochrane Ev Synth · 2025 | notes |
| Best Practice Methods for Living Evidence Synthesis: An International Modified Delphi | Preprint: a 29-expert, three-round Delphi on living-evidence practice; by the authors’ own account consensus was lowest on actionable automation use and highest on general statements, and no voted statement adjudicates AI’s reviewer role | medRxiv · 2025 | notes |
| Leveraging AI for Systematic Reviews: The FRAISR Framework | Preprint: per-stage machine-readable reporting framework | OSF · 2024 | notes |
| Transparent Reporting of AI in SLRs: PRISMA-trAIce | Checklist proposal with human/AI-split flow diagram | JMIR AI · 2025 | notes |
| HAICO-SLR: Conducting and Reporting Human-AI Collaboration in SLRs | Preprint: stage-typed human/AI role guide with dual reporting tables | SSRN · 2026 | notes |
| Reproducibility and Data Storage for Active Learning-Aided Systematic Reviews | What must be stored, not merely disclosed, for an active-learning screening pass to be reconstructable — a 15-item checklist, never applied to a completed review and demonstrated only against a tool two of its three authors develop | Appl Sci · 2024 | notes |
| LLM4SCREENLIT: Assessing LLM Performance for Screening | Measurement reform: why accuracy misleads under class imbalance | IST · 2026 | madeyski2025 |